Sign in Subscribe
United States. Securities and Exchange Commission

MannKind Corporation Enters into Commercial Supply Agreement with United Therapeutics Corporation

Strategic Insights

— 1 min read

MannKind Corporation, a biopharmaceutical company based in Westlake Village, California, has entered into a commercial supply agreement with United Therapeutics Corporation, a biotechnology company focused on pulmonary arterial hypertension (PAH) and other diseases. This agreement marks a significant milestone for MannKind, as it will be responsible for manufacturing and supplying Tyvaso DPI, an inhaled treprostinil treatment for PAH, to United Therapeutics. The supply agreement is expected to have a positive impact on MannKind's revenue and operations.

Key Takeaways:

  • MannKind Corporation has entered into a commercial supply agreement with United Therapeutics Corporation.
  • The agreement requires MannKind to manufacture and supply Tyvaso DPI and BluHale inhalation profiling devices to United Therapeutics.
  • The supply agreement has a term of two years, with automatic renewal for successive two-year terms unless terminated with 24 months' written notice.
  • The agreement includes normal and customary termination rights for both parties, including termination for material breach, liquidation, bankruptcy, or insolvency.
  • United Therapeutics will purchase the Products from MannKind on a cost-plus basis.

Statistics:

  • The agreement will continue until August 12, 2026, with automatic renewal for successive two-year terms.
  • The initial term of the agreement is two years, with either party having the option to terminate with 24 months' written notice.
  • United Therapeutics will purchase Products from MannKind on a cost-plus basis.

Sources:

  • UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 8-K _____________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 13, 2021 MannKind Corporation (Exact Name of Registrant as Specified in Charter) Delaware 000-50865 13-3607736 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number)

Read more